LINC01572 Regulates Cisplatin Resistance in Gastric Cancer Cells by Mediating miR-497-5p

Zhe Song,1 Nan Jia,1 Wei Li,1 Xiao-Yu Zhang2 1Second Department of General Surgery, Cangzhou Central Hospital, Cangzhou, Hebei Province, Mainland China; 2Department of Thyroid and Breast III, Cangzhou Central Hospital, Cangzhou, Hebei Province, Mainland ChinaCorrespondence: Xiao-Yu ZhangDepartment o...

Full description

Bibliographic Details
Main Authors: Song Z, Jia N, Li W, Zhang XY
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/linc01572-regulates-cisplatin-resistance-in-gastric-cancer-cells-by-me-peer-reviewed-article-OTT
id doaj-6f6f218f116f4b91a817083fdcc61b70
record_format Article
spelling doaj-6f6f218f116f4b91a817083fdcc61b702020-11-25T03:36:09ZengDove Medical PressOncoTargets and Therapy1178-69302020-10-01Volume 13108771088758513LINC01572 Regulates Cisplatin Resistance in Gastric Cancer Cells by Mediating miR-497-5pSong ZJia NLi WZhang XYZhe Song,1 Nan Jia,1 Wei Li,1 Xiao-Yu Zhang2 1Second Department of General Surgery, Cangzhou Central Hospital, Cangzhou, Hebei Province, Mainland China; 2Department of Thyroid and Breast III, Cangzhou Central Hospital, Cangzhou, Hebei Province, Mainland ChinaCorrespondence: Xiao-Yu ZhangDepartment of Thyroid and Breast III, Cangzhou Central Hospital, Cangzhou, Hebei Province, People’s Republic of ChinaEmail zhangxiaoyu9321@163.comBackground: Chemotherapy resistance has long been recognized as a major obstacle to cancer treatment. Therefore, elucidating the underlying mechanisms of chemotherapy resistance is conducive to developing new strategies to improve patients’ response to chemotherapy drugs.Materials and Methods: Real-time quantitative PCR (QPCR) was applied to measure the expression levels of lncRNAs. LINC01572 was down-regulated or up-regulated in GC cells transfected with either LINC01572 shRNA or overexpression vectors. In vitro and in vivo experiments were conducted to investigate the role of LINC01572 in autophagy-related chemotherapy resistance.Results: Compared with the parental cells, drug-resistant GC cells had a higher level of LINC01572. Silencing of LINC01572 inhibited chemotherapy-induced autophagy, while its knockout sensitized GC cells against chemotherapy drugs. As a competitive endogenous RNA of miR-497-5p, LINC01572 weakened the inhibitory effect of miR-497-5p on ATG14, leading to chemically induced autophagy and chemotherapy resistance in GC cells.Conclusion: A new mechanism of GC autophagy-related chemotherapy resistance regulated by lncRNA was explored in this study, providing a new perspective for understanding chemotherapy resistance.Keywords: LINC01572, miR-497-5p, gastric cancer, drug resistancehttps://www.dovepress.com/linc01572-regulates-cisplatin-resistance-in-gastric-cancer-cells-by-me-peer-reviewed-article-OTTlinc01572mir-497-5pgastric cancerdrug resistance
collection DOAJ
language English
format Article
sources DOAJ
author Song Z
Jia N
Li W
Zhang XY
spellingShingle Song Z
Jia N
Li W
Zhang XY
LINC01572 Regulates Cisplatin Resistance in Gastric Cancer Cells by Mediating miR-497-5p
OncoTargets and Therapy
linc01572
mir-497-5p
gastric cancer
drug resistance
author_facet Song Z
Jia N
Li W
Zhang XY
author_sort Song Z
title LINC01572 Regulates Cisplatin Resistance in Gastric Cancer Cells by Mediating miR-497-5p
title_short LINC01572 Regulates Cisplatin Resistance in Gastric Cancer Cells by Mediating miR-497-5p
title_full LINC01572 Regulates Cisplatin Resistance in Gastric Cancer Cells by Mediating miR-497-5p
title_fullStr LINC01572 Regulates Cisplatin Resistance in Gastric Cancer Cells by Mediating miR-497-5p
title_full_unstemmed LINC01572 Regulates Cisplatin Resistance in Gastric Cancer Cells by Mediating miR-497-5p
title_sort linc01572 regulates cisplatin resistance in gastric cancer cells by mediating mir-497-5p
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2020-10-01
description Zhe Song,1 Nan Jia,1 Wei Li,1 Xiao-Yu Zhang2 1Second Department of General Surgery, Cangzhou Central Hospital, Cangzhou, Hebei Province, Mainland China; 2Department of Thyroid and Breast III, Cangzhou Central Hospital, Cangzhou, Hebei Province, Mainland ChinaCorrespondence: Xiao-Yu ZhangDepartment of Thyroid and Breast III, Cangzhou Central Hospital, Cangzhou, Hebei Province, People’s Republic of ChinaEmail zhangxiaoyu9321@163.comBackground: Chemotherapy resistance has long been recognized as a major obstacle to cancer treatment. Therefore, elucidating the underlying mechanisms of chemotherapy resistance is conducive to developing new strategies to improve patients’ response to chemotherapy drugs.Materials and Methods: Real-time quantitative PCR (QPCR) was applied to measure the expression levels of lncRNAs. LINC01572 was down-regulated or up-regulated in GC cells transfected with either LINC01572 shRNA or overexpression vectors. In vitro and in vivo experiments were conducted to investigate the role of LINC01572 in autophagy-related chemotherapy resistance.Results: Compared with the parental cells, drug-resistant GC cells had a higher level of LINC01572. Silencing of LINC01572 inhibited chemotherapy-induced autophagy, while its knockout sensitized GC cells against chemotherapy drugs. As a competitive endogenous RNA of miR-497-5p, LINC01572 weakened the inhibitory effect of miR-497-5p on ATG14, leading to chemically induced autophagy and chemotherapy resistance in GC cells.Conclusion: A new mechanism of GC autophagy-related chemotherapy resistance regulated by lncRNA was explored in this study, providing a new perspective for understanding chemotherapy resistance.Keywords: LINC01572, miR-497-5p, gastric cancer, drug resistance
topic linc01572
mir-497-5p
gastric cancer
drug resistance
url https://www.dovepress.com/linc01572-regulates-cisplatin-resistance-in-gastric-cancer-cells-by-me-peer-reviewed-article-OTT
work_keys_str_mv AT songz linc01572regulatescisplatinresistanceingastriccancercellsbymediatingmir4975p
AT jian linc01572regulatescisplatinresistanceingastriccancercellsbymediatingmir4975p
AT liw linc01572regulatescisplatinresistanceingastriccancercellsbymediatingmir4975p
AT zhangxy linc01572regulatescisplatinresistanceingastriccancercellsbymediatingmir4975p
_version_ 1724550830018789376